ANI PHARMACEUTICALS INC — Director's Dealing 2018

Mar 7, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2018-03-05

Reporting Person: Marken James G. (SVP Ops & Prod Dev)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-05	Common Stock	M	14793	$6.36	Acquired	66439	Direct
2018-03-05	Common Stock	M	3208	$33.00	Acquired	69647	Direct
2018-03-05	Common Stock	S	4177	$61.92	Disposed	65470	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-05	Stock Options	$6.36	M	14793	Disposed	2024-03-31	Common Stock (14793)	Direct
2018-03-05	Stock Options	$33.00	M	3208	Disposed	2023-07-11	Common Stock (3208)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $62.80 to $63.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: The options vested and become exercisable in equal annual amounts over a four-year period beginning on the first anniversary of the grant date. The grant date was July 12, 2013.

F3: The options vested and become exercisable in equal annual amounts over a four-year period beginning on the first anniversary of the grant date. The grant date was April 1, 2014.